| Nicole L Fredericks, OT | |
|
3 Medical Plaza Dr, #100, Roseville, CA 95661-3087 | |
| (916) 781-1157 | |
| (916) 781-1118 |
| Full Name | Nicole L Fredericks |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapy |
| Experience | 24 Years |
| Location | 3 Medical Plaza Dr, Roseville, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215034384 | NPI | - | NPPES |
| CT0059860 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OT5986 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sutter Valley Medical Foundation | 9830094515 | 1840 |
News Archive
Amorfix Life Sciences, a company focused on treatments and diagnostics for misfolded protein diseases including Alzheimer's disease, has used its A(4) test to compare the rate of accumulation of aggregated Abeta in the brain tissue of various mouse models of AD. Amorfix presented this new data at the International Conference on Alzheimer's Disease this week.
Saint Louis University researchers have analyzed the microbiomes of people with chronic rhinosinusitis and healthy volunteers and found evidence that some chronic sinus issues may be the result of inflammation triggered by an immune response to otherwise harmless microorganisms in the sinus membranes.
Cornerstone Pharmaceuticals, Inc., a leader in cancer metabolism-based therapeutics, today announced encouraging results of a preclinical toxicity study of azide drug-loaded Emulsiphan nano emulsions conducted with the National Cancer Institute (NCI) under a Collaboration Agreement. Emulsiphan is Cornerstone's proprietary nanoparticle drug delivery system.
Hillenbrand, Inc. has entered into a definitive agreement to acquire privately held Coperion Capital, a portfolio company of Deutsche Beteiligungs AG, for an estimated purchase price of €408 million ($530 million at current exchange rates), which includes the assumption of an estimated €76 million of net debt and €100 million pension liability.
In the first Series paper, Self-harm and suicide in adolescents, Professor Keith Hawton, Dr Kate Saunders of the University of Oxford's Centre for Suicide Research, and Professor Rory O'Connor of University of Stirling's Suicidal Behaviour Research Laboratory, UK, examine existing research to look at the connections between self-harm and suicide in young people.
› Verified 9 days ago
| Provider Name | Sutter Valley Medical Foundation |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1669846986 PECOS PAC ID: 9830094515 Enrollment ID: O20090311000335 |
News Archive
Amorfix Life Sciences, a company focused on treatments and diagnostics for misfolded protein diseases including Alzheimer's disease, has used its A(4) test to compare the rate of accumulation of aggregated Abeta in the brain tissue of various mouse models of AD. Amorfix presented this new data at the International Conference on Alzheimer's Disease this week.
Saint Louis University researchers have analyzed the microbiomes of people with chronic rhinosinusitis and healthy volunteers and found evidence that some chronic sinus issues may be the result of inflammation triggered by an immune response to otherwise harmless microorganisms in the sinus membranes.
Cornerstone Pharmaceuticals, Inc., a leader in cancer metabolism-based therapeutics, today announced encouraging results of a preclinical toxicity study of azide drug-loaded Emulsiphan nano emulsions conducted with the National Cancer Institute (NCI) under a Collaboration Agreement. Emulsiphan is Cornerstone's proprietary nanoparticle drug delivery system.
Hillenbrand, Inc. has entered into a definitive agreement to acquire privately held Coperion Capital, a portfolio company of Deutsche Beteiligungs AG, for an estimated purchase price of €408 million ($530 million at current exchange rates), which includes the assumption of an estimated €76 million of net debt and €100 million pension liability.
In the first Series paper, Self-harm and suicide in adolescents, Professor Keith Hawton, Dr Kate Saunders of the University of Oxford's Centre for Suicide Research, and Professor Rory O'Connor of University of Stirling's Suicidal Behaviour Research Laboratory, UK, examine existing research to look at the connections between self-harm and suicide in young people.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicole L Fredericks, OT 10470 Old Placerville Rd, Suite 100, Sacramento, CA 95827-2539 Ph: (800) 470-0071 | Nicole L Fredericks, OT 3 Medical Plaza Dr, #100, Roseville, CA 95661-3087 Ph: (916) 781-1157 |
News Archive
Amorfix Life Sciences, a company focused on treatments and diagnostics for misfolded protein diseases including Alzheimer's disease, has used its A(4) test to compare the rate of accumulation of aggregated Abeta in the brain tissue of various mouse models of AD. Amorfix presented this new data at the International Conference on Alzheimer's Disease this week.
Saint Louis University researchers have analyzed the microbiomes of people with chronic rhinosinusitis and healthy volunteers and found evidence that some chronic sinus issues may be the result of inflammation triggered by an immune response to otherwise harmless microorganisms in the sinus membranes.
Cornerstone Pharmaceuticals, Inc., a leader in cancer metabolism-based therapeutics, today announced encouraging results of a preclinical toxicity study of azide drug-loaded Emulsiphan nano emulsions conducted with the National Cancer Institute (NCI) under a Collaboration Agreement. Emulsiphan is Cornerstone's proprietary nanoparticle drug delivery system.
Hillenbrand, Inc. has entered into a definitive agreement to acquire privately held Coperion Capital, a portfolio company of Deutsche Beteiligungs AG, for an estimated purchase price of €408 million ($530 million at current exchange rates), which includes the assumption of an estimated €76 million of net debt and €100 million pension liability.
In the first Series paper, Self-harm and suicide in adolescents, Professor Keith Hawton, Dr Kate Saunders of the University of Oxford's Centre for Suicide Research, and Professor Rory O'Connor of University of Stirling's Suicidal Behaviour Research Laboratory, UK, examine existing research to look at the connections between self-harm and suicide in young people.
› Verified 9 days ago
Tessa Tsai, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 151 N Sunrise Ave Ste 1105, Roseville, CA 95661 Phone: 916-771-8255 Fax: 916-771-8211 | |
Brittany Harlan, MS Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 151 N Sunrise Ave Ste 1105, Roseville, CA 95661 Phone: 916-771-8255 Fax: 916-771-8211 | |
Elisa Kim Kwon, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 10001 Woodcreek Oaks Blvd, #1311, Roseville, CA 95747 Phone: 916-749-4432 | |
Jill Davidson Mason, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 151 N Sunrise Ave Ste 1105, Roseville, CA 95661 Phone: 916-771-8255 Fax: 916-771-8211 | |
Frieda L Gutierrez, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2400 Pleasant Grove Blvd, Roseville, CA 95747 Phone: 916-566-5758 | |
Valerie Haskins, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 151 N Sunrise Ave, Suite 1105, Roseville, CA 95661 Phone: 916-771-8255 | |
Anna G Lee, OT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 3 Medical Plaza Dr Ste 100, Roseville, CA 95661 Phone: 916-797-4734 |